Industry: Healthcare | Publish Date: 02-Sep-2025 | No of Pages: 702 | No. of Tables: 708 | No. of Figures: 633 | Format: PDF | Report Code : HC343
The global Cone-Beam Computed Tomography (CBCT) Systems Market size was valued at USD 1.50 billion in 2024 and is predicted to reach USD 3.45 billion by 2030, with a CAGR of 10.3% from 2025 to 2030. In terms of volume the market size was 19.69 thousand units in 2024 and is projected to reach 53.72 thousand units by 2030, with a CAGR of 13.9% from 2025 to 2030.
The factors such as expansion of diagnostic imaging, high prevenance of oral health issues along with ongoing technological advancements in the CBCT system by key players accelerates the market growth at global level. However, availability of alternative imaging technologies, such as MRI and traditional CT scans, poses a significant challenge to the growth of the CBCT system market. On the contrary, the incorporation of artificial intelligence (AI) into CBCT systems offers promising future opportunities for market growth by improving diagnostic accuracy and efficiency that is expected to enhance the market expansion in the forthcoming years.
Moreover, the key players such as Planmeca OY, Koninklijke Philips N.V., Vatech Co., Ltd., Dentsply Sirona Inc., Envista Holdings, and others are taking various initiatives such as product launches, and collaboration across various countries and regions to maintain their competitive position in the market. These initiatives are fueling the growth of the market by enhancing the diagnostic and imaging capability of CBCT systems that caters to the vary changing needs of patient diagnostics and treatment planning. With advancements in CBCT systems, the scope of imaging by CBCT system is enhancing as it is no more limited to dental imaging rather it is also used for diagnosis and imaging of other body parts such as ENT, neural and spine, orthopaedic condition along with veterinary applications, ultimately accelerating the adoption of CBCT system by healthcare and diagnosis centres.
The growing healthcare industry of the diagnostic imaging segment is increasing the growth of CBCT systems, that involve advanced imaging solutions in the service of healthcare to provide diagnostic accuracy and also enhanced patient care. As stated by McKinsey & Company's report, diagnostic imaging market now accounts for USD 27.4 billion in the year 2022 and goes up to 41.6 billion in the year 2030. This expansion in the field of diagnostic imaging, increases the demand for CBCT systems by healthcare institutions to facilitate the changing needs of patient diagnosis and treatment planning.
Increasing prevalence of oral diseases such as tooth decay, periodontal disease, and oral cancers increases the use of CBCT systems for dental diagnostics and treatment planning. The WHO 2023 reported states that nearly 3.5 billion people around the world suffer from oral diseases, and while the three out of four cases of dental disease patients stayed in middle-income countries during 2022. Such rise in oral health problems as it facilitates effective patient care and preventive dental care through precise diagnosis and imaging.
Advances in CBCT systems are highly driving the market growth by improving diagnostic accuracy and workflow efficiency in medical imaging. Many key players such as Dentsply Sirona, Carestream Dental, Philips, and others in the market are continuously innovating, introducing CBCT products that enhance diagnostic accuracy and streamline workflow efficiency.
For example, in February 2024, NewTom introduced its 7G multi-scan body CBCT system, that enhances diagnostic capabilities by allowing simultaneous imaging of various anatomical areas. The introduction of such advanced CBCT systems addresses essential patient safety concerns and aligns with the increasing demand for non-invasive imaging solutions across diverse medical fields, further boosting cone-beam computed tomography (CBCT) systems market growth.
The availability of alternative imaging technologies, that encompasses MRI and traditional CT scans, poses a great challenge to the growth of the CBCT system industry. Additionally, alternative imaging technologies tend to offer more cost-effective solutions for healthcare facilities. This financial benefit leads many healthcare providers to choose MRI or conventional CT over CBCT, thereby limiting overall cone-beam computed tomography (CBCT) systems market expansion.
The integration of AI into CBCT systems is supposed to open great growth opportunities within the market in terms of high diagnostic accuracy and efficiency. It is also furthered by applications of machine learning for image optimization and predictive analytics, that should simplify workflows and reduce manual labor while enhancing efficiency and precision overall in a broad range of medical applications of CBCT imaging.
In the seg market, floor-mounted systems hold a dominating share of about 63% of the market. This substantial share indicates the widespread adoption and preference for floor-mounted CBCT systems in various medical imaging applications. These systems are favored for their stability, ease of access, and efficient workflow integration in healthcare settings. Floor-mounted CBCT systems are essential for providing high-quality imaging capabilities, supporting accurate diagnostics, and improving patient care. The dominance of floor-mounted systems highlights their critical role in advancing medical imaging technology and enhancing operational efficiency in clinical environments.
Orthopedic conditions will be the most growth-intensive segment, based on an approximately 13.3% projected CAGR of 2025-2030 period mainly because of growing musculoskeletal disorders, sport injuries, and bone-related cases. Moreover, demand for non-invasive treatment with better and more advanced image resolution is highly supporting the trend for CBCT system adoption in orthopedics.
North America includes the largest cone-beam computed tomography (CBCT) systems market share, due to high healthcare expenditure in the region that spurs providers to invest in such advanced diagnostic technologies to enhance patient care and outcomes. As indicated in the AMA report 2024, spending by the U.S. on healthcare rose to 4.1% in 2022 and hit USD 4.5 trillion in 2023.
This immense expenditure provides the opportunity for healthcare institutions to employ the latest technology such as CBCT that ensures highly accurate 3D images for critical anatomical examinations. This increased healthcare spending accelerates CBCT adoption for enhancing diagnostic accuracy and operational efficiency in the region.
Moreover, increase in government investment towards clinical trials further boosts the adoption of CBCT systems in the region by providing funding for advanced diagnostic tools essential for research. CBCT offer precise, high-resolution imaging, critical for evaluating treatment outcomes and improving clinical trial accuracy.
According to the Canadian Institutes of Health Research, over USD 76.15 million is allocated to 36 clinical trials through the CIHR Clinical Trials Fund since 2022. Such investments enable healthcare providers and research institutions to integrate CBCT technology into their protocols, enhancing diagnostic capabilities and supporting innovative medical research. This integration improves trial efficiency and drives the broader adoption of CBCT systems in clinical and healthcare settings in the region.
Asia-Pacific CBCT system industry is experiencing growth due to the fact that the region is aging, hence vulnerable to complex medical conditions demanding accurate diagnosis and thereby fueling market growth. CBCT delivers high-resolution 3D imaging, that becomes very important for detecting age-related health problems, such as degeneration of joints, bone density loss, and dental issues.
The World Economic Forum published a report that states that in 2023, two-thirds percent of the population of Japan is above 65 years numbering 36.23 million. The need for advance diagnostic tools, such as CBCT, would be more poignant with an elderly population increase in the region due to its application in early diagnosis and improved care for the region's aging populations.
In addition, the oral diseases prevalence within the region that includes tooth decay, periodontal conditions, and oral cancer is further leading to an increasing cone-beam computed tomography (CBCT) systems market demand. According to the latest report by the National Board of Examinations, within India, the severe periodontal disease affected 221 million in 2022, that further accounts for 20.3% of global cases. The growing number of oral diseases in the region means that high-tech diagnostic equipment such as CBCT systems are required for proper diagnosis and treatment of dental conditions.
Several key players operating in the cone-beam computed tomography (CBCT) systems industry include Planmeca OY, Koninklijke Philips N.V., Vatech Co., Ltd., Dentsply Sirona Inc., Envista Holdings, Cefla Medical NA (Newtom), Osstem Implant Co. Ltd., Carestream Dental Technology Limited, J. Morita Mfg. Corp., Hitachi High-Tech Group, Hefei Meyer Optoelectronic Technology Inc., Acteon Group, Genoray Co., Ltd., Xoran Technologies, LLC., Largev Instrument Corp. Ltd, Prexion Inc., HDX WILL, Apteryx Imaging Inc., CurveBeam AI, and 3Shape among others.
Note: For the latest market share analysis and in-depth CBCT system industry insights, Request for a Sample PDF Report
These companies are adopting various strategies, including product launches, and collaboration across various countries and regions to maintain their dominance in the market.
Date |
Company |
Recent Developments |
September 2024 |
DEXIS LLC |
DEXIS, a subsidiary of Envista Holdings, introduced DEXIS Connect Pro, a new software solution tailored for integrating CBCT and intraoral sensor devices. This platform enhances the digital workflow in dental practices, streamlining data management and image capture from various imaging modalities. |
July 2024 |
Vatech Co., Ltd. |
Vatech America collaborated with SICAT under a software partnership aimed at enhancing the integration of their respective technologies in the dental imaging sector. This collaboration will allow for improved interoperability between SICAT's treatment planning software and Vatech's advanced imaging systems, including CBCT system. |
June 2024
|
Vatech Co., Ltd. |
Vatech launched artificial intelligence (AI) in its diagnostic solutions, significantly enhancing the capabilities of its imaging systems, including cone beam computed tomography (CBCT). This integration aimed to improve diagnostic accuracy by automating image analysis, that facilitate faster identification of dental issues and streamline treatment planning. |
February 2024 |
Carestream Dental Technology Limited |
Carestream Dental launched the CS 8200 3D imaging series that is supposed to improve the accuracy of diagnosis in dental medicine. The system was designed based on the most advanced imaging capabilities with the focus on more complicated cases, such as endodontics, surgical assessment, and implant planning. |
March 2023 |
Planmeca OY |
Planmeca unveiled new AI-based tools for its Romexi software, aimed at improving the functionality of its imaging systems, including CBCT. This tool installed in CBCT system leverage artificial intelligence to improve the analysis of imaging data, facilitating faster and more accurate diagnostics for dental professionals. |
March 2023 |
Osstem Implant Co. Ltd. |
Osstem launched the CBCT T2 Plus system in South Korea, designed to enhance dental imaging capabilities. This system features improved resolution and speed for more accurate diagnostics. |
Floor Mounted
Wall Mounted
Seated
Supine
Standing
Image Intensifier
Flat-Panel Detector
Small FOV Systems
Medium FOV Systems
Large FOV Systems
Dental
Oral and Maxillofacial surgery (OMFS)
Endodontics
Implant Dentistry
Orthodontics
General Dentistry
Temporomandibular Joint (TMJ)
Periodontics
Forensic Dentistry
ENT Applications
Orthopedic Conditions
Neural and Spine
Veterinary
Other Application
Dental Clinics
Hospitals
Other End-User
North America
The U.S.
Canada
Mexico
Europe
The UK
Germany
France
Italy
Spain
Denmark
Netherlands
Finland
Sweden
Norway
Russia
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Singapore
Taiwan
Thailand
Rest of Asia Pacific
RoW
Latin America
Middle East
Africa
Planmeca OY
Koninklijke Philips N.V.
Vatech Co., Ltd.
Dentsply Sirona Inc.
Envista Holdings
Cefla Medical NA (Newtom)
Osstem Implant Co. Ltd.
Carestream Dental Technology Limited
J. Morita Mfg. Corp.
Hitachi High-Tech Group
Hefei Meyer Optoelectronic Technology Inc.
Acteon Group
Genoray Co., Ltd.
Xoran Technologies, LLC.
Largev Instrument Corp. Ltd
Prexion Inc.
HDX WILL
Apteryx Imaging Inc.
CurveBeam AI
3Shape
Parameters |
Details |
Market Size in 2024 |
USD 1.50 Billion |
Revenue Forecast in 2030 |
USD 3.45 Billion |
Growth Rate |
CAGR of 10.3% from 2025 to 2030 |
Market Volume in 2024 |
19.69 Thousand Units |
Volume Forecast in 2030 |
53.72 Thousand Units |
Volume Growth Rate |
CAGR of 13.9% from 2025 to 2030 |
Analysis Period |
2024–2030 |
Base Year Considered |
2024 |
Forecast Period |
2025–2030 |
Market Size Estimation |
Billion (USD) |
Growth Factors |
|
Companies Profiled |
15 |
Market Share |
Available for 10 companies |
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |